BURINEX 2 mg/4 ml IV, solution for injection in an ampoule 5 ampoules of 4 ml
Active ingredients: BUMÉTANIDE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 ampoules of 4 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BURINEX 2 mg/4 ml IV, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 4 ml
- Marketing authorisation holder
- KARO PHARMA (SUEDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Jun 2002
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61834055CIP73285842CIP133400932858422Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUMÉTANIDEsolution | 50 mg · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.